Intended Learners

This activity is intended for nurse practitioners, psychiatric nurses, and other healthcare professionals who seek to improve the care of patients with mental health disorders.

Learning Objectives

• Summarize the foundational psychopharmacology of medication classes utilized in the management of psychiatric disorders, including antidepressants, antipsychotics, mood stabilizers, and stimulants
• Employ strategies to improve patient outcomes in the management of psychiatric disorders such as ADHD, anxiety, bipolar, depression, and schizophrenia
• Implement practical strategies to develop treatment plans, optimize care, and prevent relapse
• Utilize new skills and understanding of clinical research and tools to improve patient outcomes in the acute and long-term management of mental illness

To be eligible for documentation of credit for each session attended, learners must participate in the activity and complete the session(s) and overall conference evaluations, and post-test(s), if applicable. Participants who complete the evaluation online within 60 days of the conference will receive documentation of credit. For questions regarding this activity, please email accreditation@hmpglobal.com.

Disclosure Of Relevant Financial Relationships

HMP Education is an independent provider of continuing medical education. HMP Education has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority. 

In accordance with our disclosure policies, HMP Education is committed to ensuring balance, independence, objectivity, and scientific rigor for all accredited continuing education. These policies include assigning relevance to, and mitigating, all perceived or real relevant financial relationship (conflicts of interest) between any individual with control over the content and any ineligible company (commercial interest) as defined by the ACCME and CPME. 

Any individual with control over accredited content, including planner, faculty, and reviewer, is required to globally disclose: 

1) Individual relationship(s) or lack thereof, and its nature, with any/all ineligible company, and; 

2) Any investigational, off-label, or non-FDA approved content or discussion 

HMP Education has reviewed these disclosures, assigned relevance based on the relationship and scope of content, and identified those with the potential to compromise the goals and educational integrity of the education. Relevant relationships, or lack thereof, are shared with the learner. 

Education has been independently peer-reviewed to validate content, mitigate identified financial relationships (conflicts of interest), and ensure: 

1) All recommendations involving clinical medicine is based on evidence that is accepted within the medical profession as adequate justification for their indications and contraindications in the care of patients. 

2) All scientific research referred to, reported, or used in accredited continuing education in support or justification of a patient care recommendation conforms to the generally accepted standards of experimental design, data collection, and analysis. 

3) Content is appropriate, fair and balanced, unbiased, referenced, and non-promotional. 

All relevant financial relationships have been mitigated. 

ADA Statement

HMP Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity needs accommodations, please call 770.751.7332 or 609.371.1137.

Innovation Theaters (non-accredited)

Innovation Theaters are informational sessions designed to complement your educational experience by further enhancing your knowledge and confidence of disease-states or products. No CME or CE credits are offered at these programs. By entering an Innovation Theater and having your badge scanned, you opt to share and receive information from industry sponsors. If you are from California or Maine and wish to opt out, please speak with a representative.

Use of Proprietary Names

This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred. 

Unapproved And/Or Investigational Uses of Drugs and Devices

This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the European Medicines Agency (EMA) of the European Union or the Food and Drug Administration (FDA) of the United States. Participants are strongly encouraged to consult approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed during this activity are the opinions of the respective authors, presenters or moderators and do not necessarily reflect the opinions of HMP Education.